Summarize with ChatGPT
Not all shockwave devices produce the same type of energy, and the differences are not cosmetic. Radial and focused shockwave therapies diverge in how waves are generated, how deep energy travels into tissue, and which conditions each modality is best positioned to address. For clinicians adding extracorporeal shockwave therapy (ESWT), ESWT to practice or evaluating an existing device, these distinctions shape treatment planning, patient outcomes, and ultimately the return on the capital investment.
How Focused Vs. Radial Shockwave Therapy Differ
Radial devices use a pneumatic mechanism: compressed air propels a projectile inside the handpiece, and the impact creates pressure waves that disperse outward through tissue. Energy drops off with depth, so the biological effect is strongest in superficial layers. Technically, radial devices produce pressure waves rather than true shockwaves, though many manufacturers use the terms interchangeably in marketing.
Focused shockwave devices (electrohydraulic, electromagnetic, or piezoelectric) generate true shockwaves with high peak pressure and a rapid pressure rise time. Energy converges at a defined focal depth rather than dispersing, allowing targeted delivery to deeper anatomical structures.
The table below captures the key parameters across both modalities, with broad-focused electrohydraulic shockwave included for reference.
| Clinical Parameter | Radial Shockwave Therapy | Focused Shockwave Therapy | Broad-Focused Shockwave (SoftWave TRT) |
|---|---|---|---|
| Wave type | Pressure wave (not a true shockwave) | True shockwave | True shockwave |
| Energy source | Pneumatic projectile | Electrohydraulic / electromagnetic / piezoelectric | Electrohydraulic |
| Energy distribution | Dispersive, superficial | Concentrated focal point | Parallel, broad-focused |
| Penetration depth | ~2–4 cm | Deep tissue (device dependent) | Simultaneous superficial + deep |
| Treatment field | Wide surface area | Narrow focal zone | Wide and deep (~7 × 12 cm) |
| Clinical strategy | Coverage-driven | Precision-driven | Combined depth and coverage |
| Typical indications | Superficial tendinopathy, myofascial pain | Deep tendinopathy, calcifications | Multi-depth musculoskeletal and regenerative indications |
| Operator dependency | Lower | Higher | Moderate |
Radial Shockwave Therapy: Clinical Profile and Limitations
Radial shockwave therapy is the most widely distributed ESWT modality in outpatient musculoskeletal practice, with a lower cost point and a minimal operator learning curve. Its mechanism works through mechanical nociceptor stimulation, localized circulatory changes, and fibroblastic activity that supports soft tissue adaptation.
Radial therapy performs well for superficial, diffuse presentations: myofascial trigger points, superficial tendinopathy, and plantar fasciitis are all within its effective range. Because the dispersive energy profile makes precise positioning less critical, treatments are easier to delegate to trained support staff.
The limitation is depth. Radial systems cannot maintain consistent energy delivery below the superficial tissue layer, which rules them out for calcific deposits, deep tendon insertions, or any pathology requiring structural targeting below roughly 4 cm.
READ MORE: Radial Shockwave Therapy Machines Compared
Focused Shockwave Therapy: Clinical Profile and Limitations
Focused shockwave therapy delivers true shockwave energy with a defined focal point. Because energy converges at a specific depth, focused systems can reach structures radial devices cannot: deep tendon insertions, calcific deposits, and localized degenerative changes.
Electrohydraulic, electromagnetic, and piezoelectric technologies all produce a convergent focal zone, though focal depth and volume vary across manufacturers. For conditions where the target structure is discrete and well-localized, this precision is a genuine clinical advantage.
The constraint is coverage. A narrow focal point requires precise positioning, increases operator dependency, and adds treatment time when pathology is diffuse or spans multiple tissue layers. For complex presentations, focused systems often require more sessions to achieve comparable tissue engagement.
Clinical Evidence for Radial vs. Focused Shockwave
The published evidence for both modalities tracks closely with their respective physics, and the picture that emerges from recent systematic reviews is more nuanced than a simple “focused is better for deep, radial is better for superficial” split.
For calcific shoulder tendinopathy (where a discrete, deep calcium deposit is the target), focused delivery has a clear mechanical rationale, and the evidence supports it. A 2024 systematic review and meta-analysis of 21 RCTs found ESWT produced a clinically significant advantage over sham for both pain and function at 24 weeks, with the effect driven largely by studies using focused energy protocols (Brindisino et al., 2024). Calcium deposits are structurally discrete targets, and concentrated focal energy is well-suited to that presentation.
For superficial and multi-indication musculoskeletal conditions, radial shockwave therapy has a substantial evidence base:
- Plantar fasciitis, Achilles, and patellar tendinopathy: A 2023 systematic review and meta-analysis found high-quality evidence of a large effect on pain and function for plantar fasciitis, with low-to-moderate evidence of benefit across Achilles and patellar tendinopathy (Charles et al., 2023)
- Head-to-head RSWT vs. FSWT across tendinopathies: A 2026 systematic review and meta-analysis of 530 patients comparing the two modalities directly found no clear superiority of either for pain or function overall, though moderate-quality evidence showed RSWT produced significantly greater wrist extensor strength gains in lateral epicondylitis (Stania et al., 2026)
One consistent caveat across the literature: many ESWT studies pool results across device types rather than isolating device-specific outcomes.
Where Broad-Focused Shockwave Therapy Fits
Broad-focused electrohydraulic shockwave therapy is a distinct third category, not a variation of either modality above. SoftWave TRT generates true shockwaves through plasma-initiated electrohydraulic discharge, then distributes that energy through a patented parabolic reflector to produce a parallel, broad-focused field across a ~7 x 12 cm treatment zone.
The clinical advantage is that superficial and deeper tissue layers are engaged simultaneously in a single pass. Multi-layer presentations, including plantar fasciitis with both fascial and periosteal involvement or shoulder pathology spanning multiple soft tissue depths, can be addressed without repositioning to target different depths sequentially. For providers who routinely see complex or diffuse presentations, that changes treatment efficiency in a meaningful way.
SoftWave TRT holds FDA Class II clearances beyond pain management alone, including activation of connective tissue, treatment of chronic diabetic foot ulcers, treatment of second-degree burns, and increased local blood circulation. It is recognized by the ISMST as a legitimate shockwave device and operates in the anabolic energy range (at or below 0.18 mJ/mm²), the zone that promotes tissue regeneration without cellular damage from catabolic delivery.
Adopted by Mayo Clinic, Cleveland Clinic, HSS, and treatment teams across the NFL, NBA, MLB, and PGA, SoftWave’s clinical footprint reflects operational confidence in reproducible outcomes across a wide range of indications.
Choosing the Right Shockwave Technology for Your Practice
For most clinicians, the radial vs. focused shockwave question comes down to the depth and complexity of the pathology being treated. Radial therapy fits superficial, diffuse conditions where broad coverage matters more than targeting precision. Focused therapy fits discrete deep pathology where a defined focal point is the clinical requirement. Broad-focused electrohydraulic shockwave fills the gap for multi-layer and regenerative indications where neither modality fully delivers on its own.
SoftWave TRT’s broad-focused platform is used across a wide range of clinical specialties where this distinction matters in daily practice: orthopaedic, sports medicine, podiatry, physical therapy, urology, regenerative medicine, and wound care. Across these disciplines, the ability to engage multiple tissue depths in a single pass (without the coverage constraints of a focused device or the depth limitations of a radial one) changes what is clinically achievable per session.
Clinicians ready to evaluate SoftWave against their patient population can schedule a discovery call to review indication-specific protocols and real-world data, or start the process of becoming a SoftWave provider.
